This post was originally published on Forbes Middle East
Pfizer said it is moving forward with a once-daily weight loss pill, danuglipron, after getting promising data from an early-stage trial, a milestone for the pharma giant hoping to enter the lucrative obesity drug market and compete with popular weight loss injections Wegovy and Zepbound.
…